Table. 1.

Comparison of patient profiles

Variable Pediatric-to-pediatric deceased donor liver transplantation Pediatric-to-adult deceased donor liver transplantation P-value
No. of patients 11 20 -
Recipient sex (male:female) 7:4 14:6 <0.001
Recipient age (yr) 3.0±1.8 50.2±13.6 <0.001
Primary disease NA
HBV-LC 0 11
HCV-LC 0 1
ALD 0 3
Biliary atresia 3 0
Metabolic disease 3 0
Retransplantation 2 3
Others 3 2
Recipient ABO blood group NA
A 4 8
B 2 4
O 2 7
AB 3 1
Preoperative laboratory findings
Total bilirubin (mg/dL) 7.1±6.6 20.9±15.3 0.003
Serum creatinine (mg/dL) 0.42±0.39 1.74±1.67 0.014
Prothrombin time (INR) 1.55±0.68 2.40±1.01 0.009
PELD/MELD score 14.1±5.8 30.2±9.4 <0.001
Donor sex (male:female) 7:4 9:11 0.98
Donor age (yr) 4.7±3.7 12.6±2.3 <0.001
Graft type 0.90
Whole liver 9 16
Split right liver 2 4
Graft weight (g) 435.0±108.3 1170.3±301.9 <0.001
Graft-recipient weight ratio 3.67±1.15 1.93±0.47 <0.001
Ischemic time
Cold 279.2±120.7 267.5±118.4 0.79
Warm 46.1±13.0 48.1±13.5 0.64

Values are presented as number or mean±standard deviation.

NA, not available; HBV-LC, hepatitis B virus-associated liver cirrhosis; HCV-LC, hepatitis C virus-associated liver cirrhosis; ALD, alcoholic liver disease; INR, international normalization ratio; PELD, pediatric end-stage liver disease; MELD, model for end-stage liver disease.

Korean J Transplant 2020;34:178~184 https://doi.org/10.4285/kjt.2020.34.3.178
© Korean Journal of Transplantation